A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection. [PDF]
Zhong L +18 more
europepmc +1 more source
The Kaohsiung Journal of Medical Sciences, Volume 42, Issue 6, June 2026.
Ming‐Jung Meng +3 more
wiley +1 more source
Development of EBV Related Diffuse Large B-cell Lymphoma in Deficiency of Adenosine Deaminase 2 with Uncontrolled EBV Infection. [PDF]
Gardner LS +7 more
europepmc +1 more source
Combined treatment with allogeneic Epstein-Barr- and human polyomavirus 1 specific T-cells in progressive multifocal leukoencephalopathy and EBV infection: a case report. [PDF]
Nay S +13 more
europepmc +1 more source
Gastric carcinoma harbouring loss‑of‑function mutations in the <i>PIK3R1</i>, <i>ATRX</i> and <i>RBM10</i> genes exhibits diverse histological features associated with EBV infection and <i>TP53</i> inactivation: A case report. [PDF]
Jeong SU +4 more
europepmc +1 more source
Regulation mechanism of EBV-encoded EBER1 and LMP2A on YAP1 and the impact of YAP1 on the EBV infection status in EBV-associated gastric carcinoma. [PDF]
Sun Y +5 more
europepmc +1 more source
[Analysis of CMV and EBV infection in healthy populations in China before and after the COVID-19 pandemic]. [PDF]
Zhao ZF +7 more
europepmc +1 more source
Plenary Abstracts Session & Oral Presentations
HemaSphere, Volume 10, Issue S1, June 2026.
wiley +1 more source

